WSAUA SCIENTIFIC OUTLINE OF 87TH ANNUAL MEETING

SUNDAY, AUGUST 21

Symposia Breakfast Program on Neurogenic Bladder, 6AM, Marine Room

SUNDAY, AUGUST 21 - Cypress Room

SESSION:

DVD Surgi-Session

7:30 AM - 11:30 AM

Planner: Christopher Amling, MD

Objectives:

1) Summarize applications of robotic surgery to non-cancerous conditions of the urinary tract.

2) Review anatomic factors that may complicate robotic pyeloplasty.

3) Assess new techniques in robotic prostatectomy and cystectomy.

Moderators:

Duane Baldwi

PRESENTATION #

MINUTES

DVD REC'D

PRESENTER

PAPER TITLE

Alexandra E. Rogers, M.D.

Robotic-Assisted Vesico-Vaginal Fistula Repair: The Extravesicle Tecchnique.

Jonathan N. Warner, M.D.

Robotic Resection Of Female Urethral Leiomyoma.

Jay Choe, M.D.

Use Of Single Incision Laparoscopic Surgery For Removal Of Urachal Remnants.

Sandra Koo, M.D.

Robotically-Assisted Laparoscopic Removal Of A Giant Fibroepithelial Polyp Of the Ureter.

Mark D. Tyson, M.D.

The Million Dollar Orchiectomy: What To Do With Your Robot When You Are Bored.

Ashok J. Kar, M.D.

Robotic Nephrectomy In Management Of Xanthogranulomatous Pyelonephritis (XGP).

Jennifer Linehan, M.D.

Renal Suspension During Robotic-Assisted Parital Nephrectomy.

Robert Torrey, M.D.

Robotic-Assisted Laparoscopic Partial Nephrectomy With Near Infrared Fluorescence Imaging.

Alexandra E. Rogers, M.D.

Navigating The Difficult Robotic Pyeloplasty.

Ali-Asghar Zhumkhawala, M.D.

Laparoscopic Diagnostic Retroperitoneal Lymph Node Biopsy.

Gene O. Huang, M.D

Preservation Of Pubovesical Fascia During Robotic Radical Prostatectomy.

Jennifer Linehan, M.D.

V-LOC® Anastomosis Of Neobladder During Robotic-Assisted Radical Cystoprostatectomy.

Scott M. Cheney, M.D.

Robot Assisted Simple Cystectomy, Saucerization and Debridement Of Pubic Symphysis, and Intra-Corporeal Ileal Conduit Urinary Diversion For Vesico-Symphyseal Sinus.

Andrew J. Hung, M.D.

Novel Ex-Vivo Animal Tissue Training Models For Robotic Surgery.

SUNDAY, AUGUST 21 - Bayshore Grand Ballroom

SESSION:

Poster Session I - Prostate

Modertated Session 7:30 AM - 9:30 AM

Planner: Paul E. Andrews, M.D.

Objectives:

1) Analyze the performance characteistics of PSA in patients undergoing radical prostatectomy.

2) Contrast the complications following prostate cancer therapy and better understand the management options.

3) Examine the effect of repeated biopsies on the outcome among patients treated with radical prostatectomy.

Moderators:

John Corman, MD / Ron Moore, MD

Judges: Fred Govier, MD / Eric Zeidman, MD / Paul Andrews, MD

PRESENTATION #

MINUTES

PPT REC'D

PRESENTER

PAPER TITLE

William T. Lowrance, M.D.

Locally Advanced Prostate Cancer: A Population-Based Study Of Treatment Patterns.

Sevan V. Stepanian, M.D.

Preoperative Fish Oil Supplementation Does Not Alter Operative Blood Loss or Transfusion Requirements In Patients Undergoing Radical Prostatectomy.

Bertram E. Yuh, M.D

Anatomical Extended Pelvic Lymph Node Dissection At Robot-assisted Laparoscopic Radical Prostatectomy.

Uwais B. Zaid, M.D.

Management Of Complications Following Prostate Cancer Therapy.

Bertram Yuh, M.D.

Use Of T3 MRI For Surgical Planning Of Prostate Cancer Prior To Robot-Assisted Radical Prostatectomy.

Tin C. Ngo, M.D.

Small Prostate Size and High Grade Cancer.

Brock B. O’Neil, M.D.

Impact Of Nerve Preservation During Prostatectomy On Long-Term Urinary Function.

Kirk M. Anderson, M.D.

Prostate-Specific Antigen Screening In Patients With End-Stage Renal Disease.

Ryan P. Kopp, M.D.

Do Repeated Prostate Biopsies Worsen the Outcome Among Men With Prostate Cancer Who Have a Radical Prostatectomy? Results From the Search Database.

Michael Santomauro, M.D.

Use Of Rectal Culture Specific Antibiotics For Patients Undergoing Transrectal Ultrasound Guided Prostate Needle Biopsy.

Mike M. Nguyen, M.D.

Randomized, Double-Blind, Placebo Controlled Trial Of Polyphenon E In Prostate Cancer Patients Before Radical Prostatectomy: Evaluation Of Potential Chemopreventative Activities.

Franklin C. Lee, M.D.

Upgrading At Radical Prostatectomy Between Community and Academic Urologists.

Ronald B. Moore, M.D.

Selective Intra-arterial Targeting of the Human Prostate.

Jen-Jane Liu, M.D.

Performance Characteristics of PSA in Patients Undergoing Radical Prostatectomy.

Sandra J. Koo, M.D.

Do All Patients with Gleason 8 Prostate Cancer Die of Their Disease?

Sandra J. Koo, M.D.

Do Patients with Gleason 6 Prostate Cancer Die of Their Disease?

Sandra J. Koo, M.D.

Do Multiple Prostate Needle Biopsies Cause Persistent Lower Urinary Tract Symptoms?

Michael Robinson, M.D.

Status of Robotic Assisted Surgery Among Canadian Urology Residents.

Kim E. Caramelli, M.S.

Silodosin For Men With Moderate Or Severe Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Results Of A Double-Blind, Placebo-Controlled, Phase 2 Study.

Andrew J. Hung, M.D.

Concurrent and Predictive Validities Of A Novel Robotic Surgery Simulator.

Sima P. Porten, M.D

Contemporary Trends In Imaging Use Among Men Newly Diagnosed with Clinically Localized Prostate Cancer.

Sanoj Punnen, M.D.

Multi-Institutional Validation Of UCSF Cancer Of the Prostate Risk Assessment- Postsurgical Score For Prediction Of Recurrence Post Radical Prostatectomy.

Amy E. Schlaifer, M.D.

Does Neoadjuvant Hormonal Therapy Before Salvage Cryothreapy Improve Treatment Outcomes?

John M. Corman, M.D.

Central Venous Catheter Utilization During the Impact (D9902B) Trial: A Review Of Central Venous Catheter Incidence and Associated Adverse Events.

Sandra Koo, M.D.

Can Ultrasound Performed During TRUS Biopsy Of the Prostate Enhance Our Ability To Predict Various Pathological Outcomes At Time Of Radical Prostatectomy?

Tin C. Ngo, M.D

Prostate Cancer In Vietnamese Men.

SUNDAY, AUGUST 21 - Bayshore Grand Ballroom

SESSION:

Poster Session II - Kidney & Calculi

Moderated Session 9:30 AM - 11:30 AM

Planner: Paul E. Andrews, M.D.

Objectives:

1) Distinguish the various methods of renal ischemia and the relative benefits.

2) Assess the the success and complications of percutaneous nephrolithotomy.

3) Review the management of small renal masses.

Moderators:

Alan So, MD

PRESENTATION #

MINUTES

PPT REC'D

PRESENTER

PAPER TITLE

Nathan A. Hoag, M.D

Trends In Urology Resident Exposure To Open Surgery For Index Procedures: A Tale Of Two Countries.

Gwen M. Grimsby, M.D

Surgical Treatment of Metastatic Renal Cell Carcinoma to the Pancreas.

Ryan P. Kopp, M.D.

Comparison of Partial and Radical Nephrectomy In Stage II or Greater Renal Tumors.

Keith A. Lawson, B.Sc.

Oncolytic Reovirus Therapy For Renal Cell Carcinoma.

Miranda J. Hardee, M.D.

High Grade Renal Injuries: Application of Parkland Hospital's Predictors of Intervention for Renal Bleeding to a Large Series of Patients with Blunt Renal Trauma.

Alan E. Thong, M.D.

Clinicopathologic Features and Outcomes of a Chromophobe Renal Cell Carcinoma Series From a Single Institution.

Michael Santomauro, M.D.

Reduced Port Robotic Pyeloplasty: Review of Technique and Initial Results.

Glen Yang, M.D.

Nationwide Practice Patterns for the Management of Small Renal Masses.

Damien L. Smith, M.D

Cosmetic Impact of Needlescopic Ports and Placement Techniques Upon Scarless Surgery in a Porcine Model.

Andrea A. Chan, M.D

Microscopically Positive Vein Margins Are Associated with Increased Local Recurrence and Metastatic Progression in pT3N0M0 Renal Cell Carcinoma Patients After Nephrectomy with Thrombectomy.

Seth A. Cohen, M.D.

Hyperuricemia As A Preoperative Predictor of Decline in Renal Function After Nephrectomy.

Seth A. Cohen, M.D.

Single Academic Institution Experience In Application of Laparoendoscopic Single-Site Surgery In Adult and Pediatric Urologic Surgery.

Miranda J. Hardee, M.D

Evaluation of the Appropriate Utilization of Imaging in the Diagnosis and Management of High Grade Renal Injuries.

Laura S. Leddy, M.D

Prevalence of Injury Progression on Repeat Imaging In AAST Grade IV Collecting System Injuries.

Sean Stroup, M.D.

Adverse Patient Safety Events: A Comparison of Laparoscopic and Open Partial Nephrectomy From 1998-2008.

Mukul Patil, M.D.

Intrapericardial Control for Inferior Vena Caval Thrombus.

Alex K. Wu, M.D.

Relative Renal Function Does Not Improve After Relieving Chronic Renal Obstruction.

Jonathan D. Harper, M.D.

Selective Renal Ischemia During Laparoscopic Robotic Partial Nephrectomy: Early Experience with a Parenchymal Clamp.

Megan C. Melnyk, HBSc, MSc, M.

Renal Function Following Laparoscopic Radical vs Partial Nephrectomy: A Single Institution Experience.

Robert Torrey, M.D.

The Use of Near Infrared Fluorescence Imaging During Robotic-Assisted Laparoscopic Partial Nephrectomy: The Initial Experience at City of Hope Cancer Center.

Caroline J. Colangelo, M.D.

The Nephrometry Score as A Predictor of Post Operative Renal Function After Partial Nephrectomy.

Gregory Adams, M.D.

Predicting Adverse Events in Patients Undergoing PCNL.

Ben H. Chew, MSc, M.D.

Targeted Intervention Versus Conservative Intervention for the Prevention of Kidney Stone Recurrence.

Reza Hamidizadeh, M.D.

Assessing Success and Complications of Percutaneous Nephrolithotomy in a Dedicated Stone Centre.

Dirk Lange, Ph.D.

Understanding the Role of the Urinary Conditioning Film on Bacterial Adhesion to Ureteral Stents.

Andrew J. Wright, M.D.

Fluid Intake Patterns from a Representative National Population Sample, Implications for Kidney Stone Disease Incidence.

Ben H. Chew, MSc, M.D.

Interim Analysis of a Multi-Centre Randomized Controlled Trial Comparing Three Different Modalities of Newer Lithotrites for Percutaneous Nephrolithotomy.

SUNDAY, AUGUST 21 - Stanley Park Ballroom

SESSION:

Health Policy Forum

11:45 AM - 2:30 PM

Planners: Jeffrey Kaufman, MD, / Eugene Rhee, MD

Objectives:

1) Discuss AUA, State and National Updates

2) Describe the Healthcare Delivery System in the USA.

3) Assess managing medicare and commercial contracts.

TIME

MINUTES

PPT REC'D

PRESENTER

PAPER TITLE

11:45 AM

Jeffrey Kaufman, M.D., FACS, Chairman, WSAUA Health Policy Committee, AUA Health Policy Committee

AUA, State and National Update.

12:30 PM

Sender Herschorn, M.D, Imm. Past Pres. Canadian Urological Association

The Canadian Single Payer System: What You Need to Know

1:00 PM

William F. Gee, M.D.

Your Money of Your Life - Urology 2011

1:45 PM

Howard Rubin, Attorney at Law

Urology Under Attack - The Battle at the State Level

2:15 PM

Questions & Answers, Closing Remarks & Evaluations

SESSION:

Practice Management Course #1

8:00 AM - 9:30 AM

Moderator: Amani Abou-ZamZam, MBA

TIME

MINUTES

PPT REC'D

PRESENTER

PAPER TITLE

8:00 AM - 9:30 AM

Mark Painter, PRS

Physician Reimbursement Toolkit: Reimbursement 2011 - Coding & Practice Strategies - Positioning for Success

SESSION:

Practice Management Course #2

9:45 AM - 10:30 AM

Moderator: Amani Abou-ZamZam, MBA

TIME

MINUTES

PPT REC'D

PRESENTER

PAPER TITLE

9:45 AM

Young Urologist - Matthew Cooperberg, M.D.

Primary Treatments for Clinically Localized Prostate Cancer: Systematic Review and Cost-Utility Analysis.

10:00 AM

Resident - Jeffrey Bassett, M.D.

The Impact of a Bladder Cancer Diagnosis on Smoking Behavior.

10:15 AM

William T. Lowrance, M.D., MPH

Costs Of Medical Care After Open Or Minimally Invasive Prostate Cancer Surgery: A Population-Based Analysis.

SESSION:

Practice Management Course #3

10:45 AM - 11:30 AM

Moderator: Amani Abou-ZamZam, MBA

TIME

MINUTES

PPT REC'D

PRESENTER

PAPER TITLE

10:45 AM

Presented by Kenneth A. Mitchell, MPAS, PA-C, President-Elect of UAPA

Pa’s in Urology Practice: Best Practices, Financial/Legal Considerations.

SUNDAY, AUGUST 21 - Bayshore Grand Ballroom

SESSION:

Poster Session III - Bladder, Urethra, Voiding Function

Moderated Session 2:30 PM - 4:30 PM

Planner: Paul E. Andrews, M.D.

Moderated

Objectives:

1) Analyze gene expression in superficial baldder cancer.

2) Appraise site specific disparities in survival outcomes for penile carcinoma.

3) Compare surgical techniques for urethral stricture disease.

Moderators:

Anne Schuckman, MD / Christopher Wolter, MD

PRESENTATION #

MINUTES = 2

PPT REC'D

PRESENTER

PAPER TITLE

Robert Torrey, M.D.

Management of Urteral Strictures Following Indiana Pouch Reconstruction at the Time of Robotic-Assisted Laparoscopic Radical Cystectomy.

Siamak Daneshmand, M.D.

Radical Cystectomy with Orthotopic Neobladder Reconstruction Following Prior Radical Prostatectomy.

Anirban P. Mitra, M.D.

Employment of Gene Expression Profiling and a Machine-Learning Algorithm to Predict Superficial Bladder Cancer Recurrence at Initial Presentation.

Jen-Jane Liu, M.D.

Targeted Imaging of Bladder Cancer with Molecular Contrast Agents.

Anirban P. Mitra, M.D.

Does Presence of Squamous and Glandular Differentiation in Bladder Transitional Cell Carcinoma Portend Poor Prognosis? An Intensive Case-Control Analysis.

Anirban P. Mitra, M.D.

Potential of Angiogenesis Pathway−Derived Markers in Predicting Noninvasive Bladder Cancer Recurrence.

Caroline Colangelo, M.D.

Sentinel Lymph Node (SLN) Mapping of Bladder Using Targeted SLN Tracer, Tc-99m-Tilmanocept: Pig Model.

Mark D. Tyson, M.D.

Anatomic Site-Specific Disparities in Survival Outcomes for Penile Squamous Cell Carcinoma.

Stephen Lieberman, M.D.

Novel Risk Score Assessment for Avoiding Unnecessary Workups in Patients with Asymptomatic Microscopic Hematuria.

Conrad C. Maciejewski, M.D

Differential Expression of Class I Small Leucine-Rich Proteoglycans in an Animal Model of Partial Bladder Outlet Obstruction.

Michael B. Taylor, M.D.

A Rapid and Reliable Method of Augmentation Cystoplasty and Creation of a Catheterizable Channel Using the Right Colon and Tapered Terminal Ileum.

Andrew MacNab, M.D.

Measurement of Detrusor Tissue Saturation Index (TSI) and Comparison of Detrusor Oxygenation During Urodynamics to Natural Filling / Emptying Using Wireless Near-Infrared Spectroscopy In the Neurogenic Bladder.

Alvaro Lucioni, M.D.

Long-Term Outcomes Following Transvaginal Bone-Anchored Polypropylene Sling Placement.

Herman Singh Bagga, M.D.

Epidemiology of Consumer Product-Related Genito-Urinary Injuries Presenting to United States Emergency Rooms.

Kimberly J. Hurd, B.A.

Temporary Prostatic Urterthral Stenting As A Provacauative Tool to Determine Surgical Eligability In Complex Bladder Outlet Obstructed Patients: Our Intial Experience.

Brandon R. Nadeau*, BMedSci.

Urethral Reconstruction Of Long-Segment Lichen Sclerosis Strictures: Comparison Of Surgical Techniques And Outcomes.

Allison S. Glass, M.D.

Urethroplasty After Radiation Therapy for Prostate Cancer.

Jeffrey D. Zorn, BMSc., M.D.

Reconstruction of Urethral Strictures Following Pelvic Radiation Therapy.

Keith Rourke, M.D., FRCSC

The Contemporary Presentation of Anterior Urethral Stricture: Is it Solely a Question of LUTS?

Sumeet K. Syan, M.D.

Midline Extraperitoneal Approach For Retroperitoneal Lymph Node Dissection.

Peter K. Sand, M.D

Effects Of Symptom Severity At Baseline On Oxybutynin Topical Gel–Mediated Improvement Of Continence In Women.

Joseph Chang, M.D.

Repeat Sling Surgery Using A Single Incision Mid-Urethral Sling For Women With Recurrent Stress Urinary Incontinence.

SUNDAY, AUGUST 21 - Bayshore Grand Ballroom

SESSION:

Poster Session IV - Pediatrics, Sexual Medicine, Incontinence & Potpourri - Unmoderated

Unmoderated Session

Planner: Paul E. Andrews, M.D.

Objectives:

1) Examine the effect of spinal cord deformities on ureteroscopy.

2) Asses leak point pressure in children with neurogenic bladder.

3) Compare the rate of erectile dysfunction after radical or partial nephrectomy.

PRESENTATION #

NO PODIUM

PPT REC'D

PRESENTER

PAPER TITLE

n/a

Elizabeth M. Mobley, M.D.

Timeliness Of Prophylactic Antibiotic Administration In Urologic Prosthetic Surgery: A Quality Improvement Study.

n/a

Ryan P. Kopp, M.D.

Comparison Of Rates and Risk Factors For Development Of Erectile Dysfunction After Radical or Partial Nephrectomy.

n/a

Suzanne Gudeman, M.D

Etiology Of Azoospermia In 70 Patients Referred To Urology In A System with Universal Healthcare.

n/a

Maurice M. Garcia, M.D

Light-Induced Dielectrophoresis Assay For Use In Assisted Reproduction: Is it Safe?: A Mouse Embryo Exposure and Transfer Model.

n/a

James H. Masterson, M.D.

Demographics Of Vasovasostomies Compared To Vasectomies In An Equal Access Care System: A Ten-Year Retrospective Analysis.

n/a

Michael Santomauro, M.D.

Demographics of Men Receiving Vasectomies In the US Military 2000-2009.

n/a

Su-Yeon Jang, M.D.

Report of Newly Developed Multi-layer Dissection Method Simultaneously Using Iris Scissors and Electro-cutting in Penile Enhancement Surgery.

n/a

Su-Yeon Jang, M.D.

Evaluation of Important Factors Considered By Men Who Wish To Have Penile Enhancement Surgery.

n/a

Kirk Anderson, M.D.

Staged Bilateral Nephrectomy For Autosomal Recessive Polycystic Kidney Disease: A Rare Clinical Scenario.

n/a

Alex Kavanagh, M.D.

Bladder Neck Closure In Conjunction with Enterocystoplasty and Mitrofanoff Diversion For Complex Incontinence: Closing the Door For Good.

100

n/a

Kirk M. Anderson, M.D.

Diagnosis and Treatment Of Inflammatory Myofibroblastic Tumor Of the Bladder In the Pediatric Patient: A Rare Case.

101

n/a

Gideon D. Richards, M.D.

Congenital Mesoblastic Nephroma In the Newborn.

102

n/a

Kirk M. Anderson, M.D.

Transitional Cell Carcinoma Of the Bladder In The Adolescent Patient: A Rare Case.

103

n/a

Kirk M. Anderson, M.D

Deep Bladder Biopsies In Through the 9.5 fr Offset Pediatric Cystoscope: A New Use For A Common Urologic Tool.

104

n/a

Winston Teo, M.D.

Are Patient and Urodynamic Characteristics Predictive of Detrusor Leak-Point Pressure in Children with Neurogenic Bladder?

105

n/a

Judith C. Hagedorn, M.D.

Pediatrician's Practice Patterns For Children With Vesicoureteral Reflux.

106

n/a

Caroline J. Colangelo, M.D.

Should Severe Spinal Deformities Be Considered a Relative Contraindication To Pediatric Ureteroscopy?

107

n/a

Dana A. Weiss, M.D.

Timing of Flutamide Exposure Causes Varied Degrees of Malformations in Mouse Penis and Clitoris.

108

n/a

Dana A. Weiss, M.D.

Dihydrotestosterone (DHT) and Diethylstilbestrol (DES) Affect Specific Morphologic Events in the Development of the Penis and Clitoris in Newborn Gonadectomized Mice.

109

n/a

Michael E. Moran, M.D.

Early Modern Physician Education: Harveianae.

110

n/a

Gwen M. Grimsby, M.D.

A Case Series of Female Urethral Stricture Disease.

111

n/a

Rodney U. Anderson, M.D.

OnabotuliniumtoxinA(BTX-A) For Treatment of Overactive Bladder Due to Parkinsons's Disease: Safety And Efficacy.

112

n/a

Victor E. Grigoriev, M.D.

Sacrospinous Ligament Mesh Repair Kits For Anterior Vaginal and Apical Prolapse: Safety, Results and Complications.

113

n/a

David R. Staskin, M.D.

A Once-Daily Titratable Gel Formulation For Transdermal Oxybutyinin Delivery For OAB.

114

n/a

Andrew Wright, M.D.

Systems-based Evaluation of Sequential Compression Devices In Post-operative Patients.

115

n/a

Ryan S. Hsi, M.D

Publication Misrepresentation Among Urology Residency Applicants.

116

n/a

Dana A. Weiss, M.D.

Gender Trends Of Manuscript Authorship In Urology: A 35-Year Progression.

SUNDAY, AUGUST 21 - Bayshore Grand Ballroom

SESSION:

Poster Session V - Prostate & Kidney - Unmoderated

Unmoderated Session

Planner: Paul E. Andrews, M.D.

Objectives:

1) Contrast treatments for metastatic prostate cancer.

2) Examine methods to minimize the dose of ionizing radiation with imaging techniques.

3) Compare survival rates for partial and radical nephrectomy.

PRESENTATION #

NO PODIUM

PPT REC'D

PRESENTER

PAPER TITLE

117

n/a

Thomas H. Price, M.D.

Safety Of Leukapheresis In Advanced Prostate Cancer Patients Receiving Sipuleucel-T.

118

n/a

Michael E. Moran, M.D

Theory Of the Vesicourethral Anastomosis.

119

n/a

Rafael Nuñez-Nateras, M.D.

Creation Of A Comprehensive Outcomes Analysis Unit and Biospecimens Repository For Robot Assisted Radical Prostatectomy.

120

n/a

Steven Stone, Ph.D.

CCP Score Is A Strong Predictor Of Outcome In Several Prostate Cancer Cohorts.

121

n/a

Nazish Durrani, M.D

Functional Outcomes and Results Of Erectile Function and Urinary Continence After Radical Laparoscopic Prostatetomy From A Single Centre.

122

n/a

Neal Shore, M.D.

Denosumab Versus Zoledronic Acid In Patients With Castrate-Resistant Prostate Cancer and Bone Metastases: Subgroup Analyses By Prior SRE Status and Baseline Pain Score.

123

n/a

Neal Shore, M.D.

Denosumab Treatment For Prolonging Bone Metastasis-Free Survival In Men With Castrate-Resistant Prostate Cancer.

124

n/a

Zaidi Zoubida, M.D

Trends In Prostate Cancer Incidence In Setif, Algeria Between 1987-2007.

125

n/a

Bertram Yuh, M.D

Comparison Of Standard and Extended Pelvic Lymphadenectomy During Robot-Assisted Radical Prostatectomy.

126

n/a

Myron I. Murdock, M.D.

Physician Specialty and Practice Type In Three Intergrated Phase 3 Studies Of Sipuleucel-T.

127

n/a

Anthony H. Horan, M.D.

Why Don't the University Programs Teach Microwave of BPH to the Residents? A Favorable Recent Private Practice Experience.

128

n/a

John Paul Brusky, M.D.

Prostate Cancer PSA Safety Net.

129

n/a

Mark D. Tyson, M.D.

Marital Status Predicts Prostate Cancer Specific Mortality.

130

n/a

Damien L. Smith, M.D

Comparing Radiation Exposure with Continuous and Pulsed Fluoroscopy.

131

n/a

Hossein Mirheydar, M.D.

Urolithiasis in HIV Infected Patients: Post Indinavir Era.

132

n/a

Joey Roy, M.D.C.M.

Efficacy Profile of the Storz Medical SLX-F2 Lithotriptor in Treating Renal and Ureteral Calculi.

133

n/a

Seth A. Cohen, M.D.

Establishing a Database on Nephrolithiasis Within a Renal Allograft Transplant Population – Initial Report of UC San Diego's 10 Year Experience.

134

n/a

Ryan S. Hsi, M.D

Fluoro-less Ureteroscopy: Minimizing Intraoperative Radiation During Ureteroscopic Procedures.

135

n/a

Michael E. Moran, M.D.

Rise of Modern Epistomology of Stone Disease.

136

n/a

Kirk Anderson, M.D.

Body Habitus Affects Detection of Ureteral Calculi Using Low-Dose Radiation Computed Tomography Protocols.

137

n/a

Sandra Koo, M.D.

Partial Nephrectomy Provides Equal Overall Survival and Cancer- Specific Surival Rates to Radical Nephrectomy for T1B Kidney Cancer.

138

n/a

Andrew J. Hung, M.D.

Validation of a Novel Robotic-Assisted Partial Nephrectomy Surgical Training Model.

139

n/a

Michael Santomauro, M.D

Transperitoneal Versus Retroperitoneal Minimally Invasive Partial Nephrectomy: Technical Consideration and Operative Outcomes.

140

n/a

Zhengwen Xiao,M.D.

Targeted Combination Therapies Are More Effective Than Monotherapies with Sunitinib, Sorafenib or Temsirolimus for Human Renal Cell Carcinoma - An Orthotopic Mouse Model.

141

n/a

Bertram Yuh M.D.

Integrating Robotic Partial Nephrectomy to An Existing Robotic Surgery Program.

142

n/a

Norman LaFrance, M.D.

Multicenter Phase III REDECT Trial With 124I-Girentuximab Positron Emission Tomography/Computed Tomography for the Presurgical Detection of Clear Cell Renal Cell Carcinoma.

143

n/a

Mark I. Anderson, M.D

Clinical Pathway Hastens Completion of Hematuria Referrals.

144

n/a

Robert Torrey, M.D.

Clinical Factors Involved with Postoperative Ileus Following Robotic-Assisted Laparoscopic Radical Cystectomy.

145

n/a

Eric R. G. Stockall, M.D.

Case Presentation: Use Of The Divinci Robot In Removal Of Polyethylene Pseudotumor Following Total Right Hip Arthroplasty.

146

n/a

Jennifer Linehan, M.D.

Outcomes of Robotic-Assisted Salvage Radical Cystectomy: Single Institution Case Series.

147

n/a

Zoubida Zaidi, M.D.

Bladder Cancer Incidence And Trends In Setif, Algeria Between 1986 And 2008.

148

n/a

Michael B. Taylor, M.D.

Complications Associated with Suprapubic Cystostomy: Suprapubic Cystostomy May Not Be As Well Tolerated As Previously Reported.

MONDAY, AUGUST 22

Symposia Breakfast Program on Overactive Bladder, 6AM, Marine Room

MONDAY, AUGUST 22 - Stanley Park Ballroom

SESSION:

PREP Course #1

7:45 AM - 9:45 AM

Objectives:

1) Appraise the epidemiology and risk factors of bladder cancer.

2) Discuss the management of non-muscle and muscle invasive bladder Cancer.

3) Assess treatment options for bladder cancer patients.

Faculty:

Theresa Koppie, M.D.

Jeffrey LaRochelle, MD

SESSION

TIME

PPT REC'D

PRESENTER

PAPER TITLE

Bladder Cancer

60 Mins

Theresa Koppie, M.D.

Bladder Cancer

60 Mins

Jeffrey LaRochelle, M.D.

MONDAY, AUGUST 22 - Stanley Park Ballroom

SESSION:

PREP Course #2

10:00 AM - 12 NOON

Objectives:

1) Review of lower urinary tract trauma, workup, and acute management options.

2) Define the anatomy of urethral stricture disease.

3) Describe the diagnostic techniques used in assessing urethral strictures.

4) Analyze all options for treatment of urethral stricture disease.

Faculty:

Matthew Gretzer, MD

Bryan Voelzke, MD

SESSION

TIME

PPT REC'D

PRESENTER

TOPIC

Lower Tract Reconstruction

60 Mins

Bryan Voelzke, MD

Management of Lower Urinary Tract Trauma.

Lower Tract Reconstruction

60 Mins

Matthew Gretzer, MD

Urethral Stricture Disease.

MONDAY, AUGUST 22 - Cypress Room

SESSION:

PREP Course #3

7:45 AM - 9:45 AM

Objectives:

1) Provide consultation and cost effective care of patients with antenatal hydronephrosis.

2) Diagnose and treat acute scrotal pathology.

3) Diagnose and treat common problems affecting the genitalia in children.

4) Review voiding dysfunction and its relationship to reflux, UTI and wetting.

Faculty:

Richard Rink, MD

TIME

PPT REC'D

PRESENTER

TOPIC

PREPC#3 - Common Problems in Pediatric Urology

7:45 AM - 9:

Richard Rink, MD

Symposia Lunch Program on Xgeva - Prevention of Skeletal Events in PC, 12 noon, Stanley Park Ballroom

California Urological Assoc Members Meeting, 1:15 pm, Stanley Park Ballroom

MONDAY, AUGUST 22 - Stanley Park Ballroom

SESSION:

Pelvic Floor Medicine

1:45 PM - 5:00 PM

Planner: Larissa Rodriguez, MD

Objectives:

1) Describe and discuss the pathophysiology of pelvic floor disorders including pelvic organ prolapse and urinary incontinence.

2) Identify risk factors and the epidemiology of pelvic floor disorders.

3) Compare and evaluate non-surgical and surgical treatments used to manage pelvic organ prolapse and incontinence.

Moderators:

Chris Twiss, MD / Lynn Stothers, MD

PRESENTATION #

MINUTES

PPT REC'D

PRESENTER

PAPER TITLE

149

Sender Herschorn, M.D.

Controversies in the Surgical Treatment of Female Stress Urinary Incontinence.

150

Lynn Stothers, M.D.

Near Infrared Spectroscopy of Pelvic Floor Muscles Shows the Effect Of Pelvic Floor Muscle Training In Women with Stress Incontinence.

151

Jay Choe, M.D.

The Effects of Stress on Urinary Symptoms.

152

Una Lee, M.D.

Referred Hyperalgesia, Tactile Allodynia, and Ice Water Testing In Wistar Rodents Exposed To Chronic Water Avoidance Stress.

153

Lynn Stothers, M.D.

fMRI Brain Responses To Pelvic Strengthening In Women With Idiopathic Urge Incontinence.

154

Gjanje L. Smith, M.D.

Success Of Retropubic Versus Transobturator Midurethral Slings In Obese Patients.

155

Vannita Simma-Chiang, M.D.

Urinary Functional Outcomes Of Orthotopic Urinary Diversions Using A Validated Questionnaire.

156

Gjanje L. Smith, M.D.

Comparison Of Short-term and Intermediate-term Outcomes In Patients Undergoing Transobturator Midurethral Sling.

157

Extension July 1

Victor E. Grigoriev, M.D.

De Novo Stress Urinary Incontinence In Patients Undergoing Robotic Assisted Laparoscopic Sacrocolpopexy.

158

Gjanje Smith, M.D.

Response Rates To Mailed Post-Operative Questionnaires Following Female Incontinence/Pelvic Organ Prolapse Surgery.

159

Jonathan N. Warner, M.D.

Reducing Radiation Exposure During Office Urologic Radiographic Studies.

n/a

DISCUSSION

Discussion

160

Michael Albo, MD, Kathleen Kobashi, MD

Point-Counter Point: Treatment of Refractory Overactive Bladder: Botox or Neuromodulation?

161

Moderator: Ja Hong Kim, M.D. Panelists: Una Lee, M.D., Craig Comiter, M.D., Christopher Wolter, M.D.

Panel Discussion: Management of Complications of Vaginal Surgery.

Symposia Evening Reception Program on BCG Refractory CIS of Urinary Bladder & Advanced PC, 5pm, Cypress Room

Young Urologist Program - Reception & Speaker, 5pm, Marine Room

TUESDAY, AUGUST 23

Symposia Breakfast Program on Abiraterone & Prostate Cancer, 6AM, Marine Room

TUESDAY, AUGUST 23 - Stanley Park Ballroom

SESSION:

Bladder/Urethra/ Testis

7:30 AM - 9:45 AM

Planner: Christopher Amling, MD

Objectives:

1) Summarize the indications and complications of neoadjuvant chemotherapy.

2) Describe reconstruction techniques for urethral injury and stricture disease.

3) Review surgical concepts and techniques applicable to RPLND for testicular cancer.

4) Assess surgical concepts and techniques applicable to RPLND for testicular cancer.

Moderators:

Karim Kader, MD / Daniel Dugi, MD

PRESENTATION #

MINS

PPT REC'D

PRESENTER

PAPER TITLE

162

Extension 7/13

Anirban P. Mitra, M.D., Ph.D.

Identification of a Biomarker Panel That Predicts Bladder Cancer Outcome Independent of Routine Prognostic Factors and Smoking History.

163

Glen Yang, M.D.

Value of Urethral Frozen Section at Radical Cystectomy and Impact on Intraoperative Decision Making.

164

Raveen Syan, B.S.

Factors Affecting Lymph Node Yield During Radical Cystectomy.

165

Extension 7/13

Anirban P. Mitra, M.D., Ph.D.

A Decision Tree Approach to Identifying Patients with Clinical T2 Bladder Cancer Who May Benefit From Neoadjuvant Chemotherapy.

166

Scott Cheney, M.D.

Effect of Neoadjuvant Chemotherapy on Complication Rate Following Robot Assisted Radical Cystectomy.

167

Selma Masic, B.S.

Diagnostic and Surgical Delay in Bladder Cancer and its Impact on Patient Outcome.

168

Brianna N. Harris, M.A.

Survival Following Urothelial Recurrence in Patients Post-Radical Cystectomy for Transitional Cell Carcinoma of the Bladder.

169

Adam Kinnaird, M.D.

Urethroplasty for Pelvic Fracture Urethral Distraction Defects: Factors Influencing Surgical Outcome and Erectile Dysfunction.

170

Sarah D. Blaschko, M.D.

Secondary Urethroplasty for Failed Prior Urethral Reconstruction: Outcomes of a 33 Year Experience.

171

Inder Perkash, M.D., FACS

Once A Stricture Always a Stricture; A Paradigm May not Always Be True: Durable Results and Restitution of Normal Urethra in Some Persons Following Laser Vaporization.

172

Bryan B. Voelzke, M.D

Surgical Reconstruction of Rectourethral and Urethropelvic Fistulas.

173

Sandra Koo, M.D.

Increased Number Of Nodes Removed At Retroperitoneal Lymph Node Dissection Improves Overall- and Cancer-Specific Survival In Patients With Testicular Cancer.

174

Michael Santomauro, M.D.

Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection For Testicular Cancer: Early Experience and Initial Results.

175

Emmanuel J. Mitsinikos, B.S.

Nerve-Spring Retroperitoneal Lymph Node Dissection In Metastatic Testicular Cancer.

176

Will submit slid

Theresa Koppie, M.D.

Update on the Treatment and Surveillance of Non-Muscle-Invasive Bladder Cancer.

REFRESHMENT BREAK IN EXHIBIT HALL - 9:45 AM - 10:30 AM

TUESDAY, AUGUST 23 - Stanley Park Ballroom

SESSION:

Pediatrics

10:30 AM - 12:00 PM

Planner: Tony Khoury, MD

Objectives:

1) Appreciate the factors involved in recurrent UTI's and epididymitis in children and preventative measures.

2) Discuss novel approaches to the prevention of postoperative pain in children.

3) Describe the principles and correlation between simple manomatery performed at home.

Moderators:

Andrew MacNeily, MD / Catherine DeVries, MD

PRESENTATION #

MINS

PPT REC'D

PRESENTER

PAPER TITLE

177

Kourosh Afshar, M.D.

Cranberry Juice for the Prevention of Pediatric Urinary Tract Infection: A Quadruple Blind Randomized Controlled Trial.

178

A. Scott Polackwich Jr., M.D.

Long Term Follow Up After Endoscopic Treatment of Vesicoureteral Reflux with Dextanomer/Hyaluronic Acid Co-polymer In Patients with Neurogenic Bladder.

179

Catherine R. deVries, M.D.

Epididymitis In Children; New Insights On An Old Problem.

180

Tony Khoury, M.D.

Application Of Continuous Infusion Of Local Anesthetic After Major Pediatric Urological Surgery.

181

Andrew L. Freedman, M.D

The Use of A Novel Video Telescopic Operating Microscope (VITOM) in Hypospadias Surgery: A Feasibility Trial.

182

Tony Khoury, M.D.

Correlation Of End Pressure Measured By A Simple Ruler Manometry and By Cystometrogram.

183

1-Aug

Tony Khoury, M.D.

Will Tissue Engineered Bladders ever become clinically available?

184

1-Aug

Andrew MacNeily, M.D. - Pro Richard Rink, M.D. - Con

Point/Counter Point: Neurogenic Bladder: Augmentation is over used and has limited role in improving the QOL.

185

1-Aug

J. Christopher Austin, M.D.

Current Recommendations for Prophylactic Antibiotics in Patients with VUR.

TUESDAY, AUGUST 23

Symposia Lunch Program on Wellness for Prostate Cancer Patients, 12 noon, Stanley Park Ballroom

TUESDAY, AUGUST 23 - Stanley Park Ballroom

SESSION:

History Essay Presentations

1:30 PM - 1:55 PM

Planner: Lawrence W. Jones,

Objectives:

Discuss the historical urological value value to our attendees.

Moderators:

Sakti Das, MD / Martin Dresner, MD

PRESENTATION #

MINS

PPT REC'D

PRESENTER

PAPER TITLE

186

Michael E. Moran, M.D.: Tucson,

Avatars and Simulacra.

187

Anthony H. Horan, M.D.: Delano,

The History of Medical Castration.

188

Michael E. Moran, M.D.: Tucson,

Hidden In Plain Sight.

TUESDAY, AUGUST 23 - Stanley Park Ballroom

SESSION:

Special Talks

PPT REC'D

PRESENTER

PAPER TITLE

189

Lawrence W. Jones, M.D.

UROPAC Update.

190

1-Aug

Christopher Welty, M.D.

IVU Presentation: Experience in Ajmer, India: December 25-29, 2010.

191

D. Nachtsheim t

Sushil Lacy, M.D., AUA President

AUA Foundation Update.

192

George W. Drach, M.D.

Medicare, Urology and You.

TUESDAY, AUGUST 23 - Stanley Park Ballroom

SESSION:

Sexual Medicine

2:15 PM - 3:00 PM

Planner: Tony Khoury, MD

Objectives:

1) Discuss treatment options of Lichen Sclerosus for disease prevention progression.

2) Analyze neurological controls of the male sexual response.

3) Review penile plaque incisions and temporalis fascia grafting.

Moderators:

Maurice Garcia, MD / Claire Yang, MD

PRESENTATION #

MINS

PPT REC'D

PRESENTER

PAPER TITLE

193

Timothy Tausch, M.D.

Early Aggressive Treatment Of Lichen Sclerosus May Prevent Disease Progression.

194

Donald Hannoun, M.D.

Penile Plaque Incision and Temporalis Fascia Grafting In Peyronie’s Disease.

195

Claire C. Yang, M.D.

Neurological Control of the Male Sexual Response.

REFRESHMENT BREAK IN EXHIBIT HALL - 3:00PM - 3:30 PM

TUESDAY, AUGUST 23

SESSION:

Prostate 1

3:30 PM - 5:00 PM

Planner: Herbert Ruckle, MD

Objectives:

1) Discuss treatment options for locally advanced prostate cancer.

2) Examine the learning curve and methods of adopting robotic prostatectomy into a physician's practice.

3) Describe risk calculators and nomograms for prostate cancer risk into clinical practice.

Moderators:

Daniel Lin, MD / Kelly Parsons, MD

PRESENTATION #

MINS

PPT REC'D

PRESENTER

PAPER TITLE

196

Seth A. Cohen, M.D.

A Progressive Training Program In Robotic-Assisted Laparoscopic Prostatectomy: Comparative Outcomes Within A Veterans' Affairs Population.

197

Mitchell R. Humphreys, M.D.

Natural Orifice Transluminal Endoscopic Radical Prostatectomy (NOTES RP): Initial Peri-Operative and Pathological Results.

198

Patrick S. McDonough, M.D.

The Impact Of Robotics On Radical Prostatectomy Training In Urology Residency: A Survey Of AUA Resident Members Worldwide.

199

Extension 7/13

Sanoj Punnen, M.D.

Does the Use and Timing Of Androgen Deprivation Therapy For Biochemical Recurrence After Radical Prostatectomy Affect Prostate Cancer Specific Mortality?

200

William T. Lowrance, M.D., MPH

Treatment of Locally Advanced Prostate Cancer.

201

Torrence M. Wilson, M.D.

Positive Margins At the Seminal Vesicles In Prostatectomy Patients: Rationale For Adjuvant Radiation Therapy.

202

Adam C. Reese, M.D.

Quantitative Gleason Grading Improves Prostate Cancer Risk Stratification.

203

Tin C. Ngo, M.D.

The Stanford Prostate Cancer Risk Calculator.

204

Ryan P. Dorin, M.D.

Outcomes Of Patients With Lymph Node Positive Prostate Cancer Treated With Surgery Only In the PSA Era.

WEDNESDAY, AUGUST 24 - Stanley Park Ballroom

Special Talks

MINS

PRESENTER

PAPER TITLE

205

Sushil S. Lacy, M.D.

AUA Presidential Address "AUA Update and What Does AUA Mean To Me."

206

Stephen KB Chinn, M.D.

WSAUA Presidential Address "Changes in Medicine."

WEDNESDAY, AUGUST 24

SESSION:

Calculi

9:30 AM - 10:15 AM

Planner: Mitchell Humphreys, MD

Objectives:

1) Describe the pitfalls of stone retropulsion and techniques to prevent its occurance.

2) Conceptualize the importance of oxalate metabolism and the potential strategies to impact patient care.

3) Realize the importance of CT techniques and the attention of nephrolithiasis.

Moderators:

Ryan Patterson, MD & Roger Low, MD

PRESENTATION #

MINS

PPT REC'D

PRESENTER

PAPER TITLE

207

Jason Sea, M.D.

Holmium: Yag Lithotripsy: Effect of Power Settings and Anti-Retropulsion Devices.

208

James H. Masterson, M.D.

The Impact of Statins on Nephrolithiasis: A Ten-Year Review of an Equal Access Health Care System.

209

Dirk Lange, Ph.D.

Understanding Oxalate Metabolism and the Role of Oxalobacter Formigenes as a Possible Treatment.

210

Damien L. Smith, M.D.

Comparing Stone Attenuation in Low-Dose and Conventional Noncontrast Computerized Tomography.

211

Mathew D. Sorensen, M.D.

Impact Of Calcium Intake and Intestinal Calcium Absorption On Kidney Stones In Older Women: The Study Of Osterporotic Fractures (SOF).

212

1-Aug

Mihir M. Desai, M.D.

New Technology and Stone Disease.

REFRESHMENT BREAK IN EXHIBIT HALL - 10:15 AM - 11:00 AM

WEDNESDAY, AUGUST 24 - Stanley Park Ballroom

KEYNOTE SPEAKER

MINS

PPT REC'D

PRESENTER

PAPER TITLE

213

N/A

Story Musgrave, Astronaut

Featured Speaker - Expeditions and Adventures in Space.

WEDNESDAY, AUGUST 24

Symposia Lunch Program on Immunotherapy for Advanced Prostate Cancer, 12 noon, Stanley Park Ballroom

WEDNESDAY, AUGUST 24

SESSION:

Kidney & Laparoscopy

1:30 PM - 3:00 PM

Planner: Mitchell Humphreys, MD

Objectives:

1) Describe the different methods of diagnosing renal mass including biopsy techniques and imagery.

2) Discuss the importance of renal preservation for chronic renal disease, hyperlipidemia and diabetes.

3) Assess the radiographic impact of minimally invasive techniques for the treatment of small renal masses.

Moderators:

James L'Esperance, MD / Gary Chien, MD

PRESENTATION #

MINS

PPT REC'D

PRESENTER

PAPER TITLE

214

Gwen M. Grimsby, M.D.

A Double Blinded Randomized Controlled Trial Of Continuous Intravenous Ketorolac Versus Placebo For Postoperative Pain Control Following Renal Surgery.

215

Damien L. Smith, M.D.

Radiation Doses Received During Radiofrequency Ablation and Cryoablation Treatment of Small Renal Tumors.

216

Ryan P. Kopp, M.D

Use of Computed Tomography To Predict Renal Tumor Histology.

217

Melanie Wuerstle, M.D.

Accuracy and Implication of Percutaneous Renal Biopsy in the Management of Renal Masses.

218

Catherine R. Harris, M.D.

Under-Grading on Renal Mass Biopsy in Patients with <4cm Renal Masses Undergoing Ablation.

219

Jared M. Whitson, M.D.

Population Based Comparative Effectiveness Of Nephron Sparing Surgery Versus Ablation For Small Renal Masses.

220

Sean Stroup, M.D.

Does Timing of Cytoreductive Nephrectomy Impact Patient Survival with Metastic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era?

221

Tin C. Ngo, M.D.

Estimating the Risk of Chronic Kidney Disease after Nephrectomy.

222

Ryan P. Kopp, M.D.

Comparison of Rates and Risk Factors for Development of Hyperlipidemia after Radical or Partial Nephrectomy.

223

Ryan P. Kopp, M.D.

Variation In Prevalence Of and Risk Factors For Development Of Diabetes Mellitus Following Radical Or Partial Nephrectomy.

224

1-Aug

Panel: James Porter, MD, Indibir Gill, MD, MODERATOR: Erik Castle, MD

Panel Discussion on Controversies and Management Options for Renal Ischemia During Partial Nephrectomy.

WEDNESDAY, AUGUST 24 - Stanley Park Ballroom

SESSION:

Prostate 2

3:00 PM - 5:30 PM

Planner: Herbert Ruckle, MD

Objectives:

1) Review new systematic therapies for metastatic prostate cancer.

2) Describe various non-medical therapies for BPH/LUTS.

3) Incorporate current information on complications of prostate biopsy into clinical practice.

Moderators:

Peter Black, MD / Bruce Dalkin, MD / Chris Dechet, MD

PRESENTATION #

MINS

PPT REC'D

PRESENTER

PAPER TITLE

PRESENTER

225

Nick Tadros, M.D.

Evolution Of Practice Patterns In Transrectal Ultrasound-Guided Prostate Biopsy: A Questionnaire Survey Of Practicing Urologists.

226

Liyan Zhuang, M.D., Ph.D.

Reduced Rate Of Infective Complications After Initial Prostate Biopsy Using A Uniformed Pre-Biopsy Protocol: Single Institution Experience With ,194 Patients.

227

Matthew R. Cooperberg, M.D., M

Contemporary Nationally-Representative Trends In Primary Treatment For Localized Prostate Cancer.

228

1-Aug

Martin Gleave, M.D.

Current Status of Systemic Therapy for Advanced Prostate Cancer Highlighting Recently Approved and Emerging Therapies.

229

Thomas Ahlering, M.D.

Preventing Major To Minor Complications: Experience After 1,000 Robotic-Assisted Radical Prostatectomies.

230

Extension 7/16

John M. Corman, M.D.

Do Patients Undergoing Robotic Prostatectomy Have A Shorter Hospital Stay Than Open Surgical Patients?

231

John R. Gannon, M.D.

Radical Retropubic Prostatectomy VS Robot Assisted Laparoscopic Radical Prostatectomy: A Quality Of Life Comparison.

232

Christopher J. Welty, M.D.

Current Use Of Brachytherapy and Cryotherapy By Risk Level For Prostate Cancer In the United States.

233

1-Aug

Andrew Southwick, M.D.

Non-Medical Therapies for BPH.

234

Heather Willis, M.D.

Prospective Randomized Trial Comparing KTP Laser PVP, Bipolar, and Monopolar Transurethral Resection Of the Prostate for Benign Prostatic Hypertrophy.

235

Gwen M. Grimsby, M.D.

The Changing Nature Of BPH Treatment: The Effect Of HoLEP On Patient Geographic Distribution.

236

Extension 8/1

Sanoj Punnen, M.D.

What Is the Prevalence and Impact Of Depression, Anxiety, and Distress In Patients Newly Diagnosed With Localized Prostate Cancer.

THURSDAY, AUGUST 25

SESSION:

Round Table Program

9:00 AM - 11:00 AM

Planners: John Barry, MD & John Prince, MD

Objectives:

1) Apply at least one new technique for the treatment of urological disease.

2) Have fun learning the new technique(s).

Moderators:

John Barry, MD / John Prince, MD

Judges: Fred Govier, MD / Stephen Chinn, MD / Sushil Lacy, MD

PRESENTATION #

MINS

PPT REC'D

PRESENTER

PAPER TITLE

237

Suzanne Gudeman, M.D.

Sleeve Versus Forceps Guided Technique For Mass Circumcision Efforts For HIV Prevention.

238

Gjanje L. Smith, M.D

Malignant Priapism As A Presenting Symptom of Metastatic Bladder Cancer.

239

Seth A. Cohen, M.D.

The Wrench - A Story of Phallic Trauma.

240

John Paul Brusky, M.D.

Penis Enlargement; A Cautionary Tale.

241

Amy E. Schlaifer, M.D.

From Libya with Love.

242

Jeffrey D. Zorn, BMSc., M.D.

An Interesting Case Of Scrotal/Labial SCC and Seminoma In A Partial Androgen Insensitive Male.

243

Judith C. Hagedorn, M.D.

Bigger Is Not Always Better: A Report on a Potentially Life-Threatening Sexual Practice.

244

Might not prese

Uwais B. Zaid, M.D.

Intratesticular Abscess.

245

Richard N. Greene Jr., M.D.

Single Incision Laparoscopic Orchiectomy, A Case Report.

246

Anthony H. Horan, M.D

30 Books for the General Reader About Prostate Cancer Have Been Published since 1996; Why so Many?

247

Anthony H. Horan, M.D

Can a Neurological Exam of S1-S4 Substitute for Urodynamic Studies Prior to Repair of Stress Urinary Incontinence.

248

Anthony H. Horan, M.D

Herpes Zoster (shingles) of the Bladder without Skin Vesicles or Urinary Retention.

249

Timothy J. Tausch, M.D

The Matryoshka Stone.

250

Maurice M. Garcia, M.D.

Feasibility Study: A Novel Ultra-Small Gold Micro-Tyned Fiduciary Marker Design and Delivery Protocol To Improve Conformal Radiation Therapy For Bladder Cancer.

251

Scott M. Cheney, M.D.

The Crown Test: A New Diagnostic Tool for Entero-vesical Fistula.

252

Gene O. Huang, M.D.

A Trick of the Trade for When You Can Knot Remove a Ureteral Stent.

253

John R. Gannon, M.D.

Renal Trauma In An Interesting Anatomic Variant.

254

John M. Barry, M.D.

Ten Questions.